$14 million (Series A-1) raised in GV-led round to treat hair loss
Pelage Pharmaceuticals, a clinical-stage regenerative medicine company developing a new generation of hair loss treatments, announced that the first patients have been treated in its Phase 2a clinical trial evaluating…